SNWV Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
9.7M
+1.2%
9.6M
-26.5%
13.1M
+14.3%
11.5M
+13.9%
10.1M
Cost of Revenue
2.3M
+5.8%
2.2M
-35.5%
3.4M
+34.3%
2.5M
+14.5%
2.2M
Gross Profit
7.4M
-0.1%
7.4M
-23.4%
9.7M
+8.7%
8.9M
+13.7%
7.8M
Operating Expenses
7.7M
-9.9%
8.6M
-5.9%
9.1M
+21.8%
7.5M
+16.3%
6.4M
R&D
628.0K
-4.8%
660.0K
+8.9%
606.0K
+75.7%
345.0K
+77.8%
194.0K
SG&A
6.8M
-10.8%
7.6M
-6.6%
8.2M
+18.8%
6.9M
+14.1%
6.0M
Operating Income
-280000
+75.1%
-1124000
-282.8%
615.0K
-58.1%
1.5M
+2.0%
1.4M
EBITDA
33.0K
+104.0%
-830000
-186.9%
955.0K
-44.2%
1.7M
+5.9%
1.6M
Net Income
-682000
+52.6%
-1439000
-123.6%
6.1M
-40.8%
10.3M
+1773.9%
551.0K
EPS (Basic)
$-0.08
+52.9%
$-0.17
-123.9%
$0.71
-40.8%
$1.20
+1900.0%
$0.06
EPS (Diluted)
$-0.08
+52.9%
$-0.17
-126.6%
$0.64
+39.1%
$0.46
+1250.0%
$-0.04
Shares (Diluted)
8.6M
+0.1%
8.6M
-9.3%
9.5M
+3.6%
9.1M
-0.3%
9.2M
SANUWAVE Health (SNWV) โ€” Financials